Capricor Therapeutics Income Statement (2011-2025) | CAPR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)	0.04M	0.20M				0.19M	1.59M	0.96M	2.99M	3.92M	6.19M	12.09M	10.00M	3.97M	2.26M	11.13M	0.01M
Operating items
Research & Development (Quarter)	3.30M	3.50M	2.50M	4.26M	5.12M	5.00M	5.50M	6.23M	7.66M	8.80M	10.03M	9.90M	11.10M	12.50M	11.80M	14.57M	18.92M	22.00M	20.36M	23.15M
Selling, General & Administrative (Quarter)	1.91M	1.79M	1.80M	2.12M	2.72M	2.36M	2.56M	2.79M	3.51M	2.85M	3.02M	3.43M	4.07M	3.06M	3.46M	4.27M	6.07M	5.67M	5.92M	6.02M
Restructuring Costs (Quarter)															1.14M				2.61M
Other Operating Expenses (Quarter)	-0.00M		0.01M			-0.03M	0.00M	-0.03M		0.02M	-0.01M	-653.00		0.00M	-1.13M	-0.01M	-0.15M		-0.01M
Operating Expenses (Quarter)	5.20M	5.29M	4.31M	6.38M	7.83M	7.32M	8.07M	9.03M	11.17M	11.66M	13.05M	13.37M	15.17M	15.56M	15.27M	18.83M	24.98M	27.72M	26.28M	29.16M
Operating Income (Quarter)	-5.16M	-5.08M	-4.31M	-6.38M	-7.83M	-7.32M	-6.48M	-8.07M	-8.18M	-7.75M	-6.86M	-1.28M	-10.27M	-11.59M	-13.01M	-7.70M	-24.98M	-27.72M	-26.28M	-29.16M
EBIT (Quarter)	-5.16M	-5.08M	-4.31M	-6.38M	-7.83M	-7.32M	-6.48M	-8.07M	-8.18M	-7.75M	-6.86M	-1.28M	-10.27M	-11.59M	-13.01M	-7.70M	-24.98M	-27.72M	-26.28M	-29.16M
Non-operating items
Interest & Investment Income (Quarter)	0.01M	0.02M	0.02M	0.02M	0.01M	0.02M	0.11M	0.38M	0.42M	0.38M	0.48M	0.45M	0.47M	0.59M	0.45M	0.69M	0.73M	1.79M	1.71M	2.02M
Other Non Operating Income (Quarter)		0.32M
Non Operating Income (Quarter)	0.01M	0.33M	0.38M	0.19M	0.01M	0.21M	0.11M	0.35M	0.42M	0.38M	0.47M	0.52M	0.47M	0.59M	0.45M	0.58M	0.59M	1.81M	1.71M	-1.01M
Net income details
EBT (Quarter)	-5.15M	-5.07M	-4.30M	-6.36M	-7.82M	-7.30M	-6.37M	-7.69M	-7.77M	-7.37M	-6.39M	-0.83M	-9.79M	-11.00M	-12.56M	-7.01M	-24.25M	-25.93M	-24.57M	-27.13M
Profit After Tax (Quarter)	-5.15M	-4.75M	-3.93M	-6.19M	-7.82M	-7.11M	-6.37M	-7.72M	-7.77M	-7.37M	-6.39M	-0.76M	-9.79M	-11.00M	-12.56M	-7.12M	-24.39M	-25.91M	-24.57M	-30.17M
Income from Continuing Operations (Quarter)	-5.15M	-5.07M	-4.30M	-6.36M	-7.82M	-7.30M	-6.37M	-7.69M	-7.77M	-7.37M	-6.39M	-0.83M	-9.79M	-11.00M	-12.56M	-7.01M	-24.25M	-25.93M	-24.57M	-27.13M
Consolidated Net Income (Quarter)	-5.15M	-5.07M	-4.30M	-6.36M	-7.82M	-7.30M	-6.37M	-7.69M	-7.77M	-7.37M	-6.39M	-0.83M	-9.79M	-11.00M	-12.56M	-7.01M	-24.25M	-25.93M	-24.57M	-27.13M
Income towards Parent Company (Quarter)	-5.15M	-5.07M	-4.30M	-6.36M	-7.82M	-7.30M	-6.37M	-7.69M	-7.77M	-7.37M	-6.39M	-0.83M	-9.79M	-11.00M	-12.56M	-7.01M	-24.25M	-25.93M	-24.57M	-27.13M
Net Income towards Common Stockholders (Quarter)	-5.15M	-5.07M	-4.30M	-6.36M	-7.82M	-7.30M	-6.37M	-7.69M	-7.77M	-7.37M	-6.39M	-0.83M	-9.79M	-11.00M	-12.56M	-7.01M	-24.25M	-25.93M	-24.57M	-27.13M
Additional items
EPS (Basic) (Quarter)	-0.23	-0.21	-0.17	-0.26	-0.32	-0.29	-0.26	-0.31	-0.31	-0.29	-0.25	0.02	-0.31	-0.35	-0.38	-0.11	-0.53	-0.57	-0.54	-0.62
EPS (Weighted Average and Diluted) (Quarter)	-0.23	-0.21	-0.17	-0.26	-0.32	-0.29	-0.26	-0.31	-0.31	-0.29	-0.25	0.02	-0.31	-0.35	-0.38	-0.11	-0.53	-0.57	-0.54	-0.62
Shares Outstanding (Weighted Average) (Quarter)	22.23M	22.86M	0.13M	0.11M	0.11M	24.30M	0.11M	0.11M	0.11M	0.11M	0.11M	5.04M	5.04M	5.04M	33.09M	4.94M	45.64M	45.67M	45.69M	46.48M
Shares Outstanding (Diluted Average) (Quarter)	22.23M	22.86M	22.73M	23.09M	24.28M	24.30M	24.43M	24.55M	25.25M	25.29M	25.47M	26.78M	31.35M	31.60M	32.10M	35.22M	45.64M	45.67M	45.69M	46.48M
EBITDA (Quarter)	-5.20M	-4.70M	-3.90M	-6.20M	-7.82M	-7.10M	-6.30M	-7.70M	-7.78M	-7.28M	-6.50M	-0.68M	-9.72M	-11.20M	-12.62M	-6.18M	-23.61M	-26.30M	-25.11M	-30.70M
Interest Expenses (Quarter)

Research Tools

Capricor Therapeutics Income Statement (2011-2025) | CAPR

Create an account

Sign In

Reset Password